期刊文献+

舒芬太尼复合右美托咪定在髋关节置换术后镇痛中的应用 被引量:2

Application of sufentanil combined with dexmedetomidine in hip arthroplasty analgesia
下载PDF
导出
摘要 目的:探讨舒芬太尼复合右美托咪定在髋关节置换术后镇痛中的应用效果。方法:选取收治的行髋关节置换术患者40例作为研究对象,按照随机数字表法将其分成2组,每组20例。观察组给予舒芬太尼复合右美托咪定镇痛,对照组给予舒芬太尼镇痛,比较2组患者术后4 h(T_1),8 h(T_2),12 h(T_3),24 h(T_4),48 h(T_5)的视觉模拟疼痛(VAS)评分,Ramsay镇静评分及不良反应的发生情况。结果:观察组术后T_1,T_2,T_3,T_4,T_5的VAS评分较对照组均明显降低(P<0.01);观察组术后T_1,T_2,T_3,T_4,T_5的Ramsay镇静评分较对照组明显升高(P<0.01);2组不良反应发生率差异无统计学意义(P>0.05)。结论:舒芬太尼复合右美托咪定在髋关节置换术后镇痛中效果显著,值得临床推广应用。 Objective: To explore the application effect of sufentanil combined with dexmedetomidine in hip arthroplasty analgesia.Methods: 40 cases of hip replacement patients treated in our hospital from April 2015 to June 2016 were selected and divided into two groups,20 cases in each.The observation group was given sufentanil combined with dexmedetomidine analgesia,and the control group was given sufentanil analgesia only.Then the visual analogue scale (VAS) pain score,Ramsay sedation score and adverse reaction were compared between the two groups at 4h (T_1),8h (T_2),12h (T_3),24h (T_4) and 48h (T_5) after the operation.Results: The VAS scores of the observation group were significantly lower than those of the control group at T_1,T_2,T_3,T_4 and T_5 after the operation (P 0.01); the Ramsay sedation scores in the observation group were significantly higher than those in the control group at T_1,T_2,T_3,T_4 and T_5 (P 0.01); there was no significant difference in the incidence of adverse reactions between the two groups (P 0.05).Conclusion: The efficacy of dexmedetomidine combined with sufentanil in the application of postoperative analgesia after the hip replacement is significant,which is worthy of clinical application.
作者 汤芸芸
出处 《淮海医药》 CAS 2017年第5期527-528,531,共3页 Journal of Huaihai Medicine
关键词 关节成形术 置换 舒芬太尼 右美托咪定 镇痛 Arthroplasty replacement hip Sufentanil Dexmedetomidine Analgesia
  • 相关文献

参考文献8

二级参考文献76

  • 1敬勇君,曲超,姬桂荣,邹昌骝,张原,邓超,徐宝林,陈姜.不同剂量右美托咪啶复合舒芬太尼用于骨科术后镇痛的效果[J].中华临床医师杂志(电子版),2012,6(21):7001-7003. 被引量:14
  • 2佘守章.新型阿片类药物在病人自控镇痛中应用研究的进展[J].临床麻醉学杂志,2006,22(11):874-877. 被引量:23
  • 3Ebert T J, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans[J]. Anesthesiology, 2000, 93(2): 382-394.
  • 4Mcvey JD, Tobias JD. Dexmedetomidine and ketamine for sedation during spinal anesthesia in children[J]. Clin Anesth, 2010, 22(7):538-545.
  • 5Al-Mustafa MM, Badran IZ, Abu-Ali HM, et al. Intravenous dexmedetomidine prolongs bupivacaine spinal analgesia[J]. Middle East J Anesthesiol, 2009, 20(2): 225-231.
  • 6Cooper L, Candiotti K, Gallagher C, et al. A randomized, conlrolled trial on dexmedetomidine for providing adequate sedation and hemodynamic control for awake, diagnostic transesophageal echocardiography[J]. J Cardiothorac Vasc Anesth, 2011, 25(2): 233-237.
  • 7林玉婵,刘卫江,等.182例机械通气患者Ramsay镇静评分的应用和护理[J].国际医药卫生报道,2010,16(18):2302-2304.
  • 8Bradley C. Dexmedetomidine-a novel sedative for postoperative sedation[J]. Intensive Crit Care Nurs, 2000, 16(5): 328-329.
  • 9Kamibayashi T, Maze M. Clinical uses of alpha2 -adrenergic agonists[J]. Anesthesiology, 2000, 93(5): 1345-1349.
  • 10Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial[J]. JAMA, 2009, 301(5): 489-499.

共引文献156

同被引文献20

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部